2023Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis.
Pulmonary therapy.9(2):237-253[DOI] 10.1007/s41030-023-00222-2.[PMID] 37072607.